There are three brands increase therapy.

Specific therapy became available forPAlpha-1 of 1987: Class medicine called increase in therapy. This medicine replaces alpha-1 antitrypsin protein in the blood of normal alpha-1 antitrypsin in lasix drug heart plasma of healthy donors, and it is given into a vein. The dose is adjusted based on body weight, and is often treated once a week. There are three brands increase therapy. They include:

lung transplantation or lung reduction surgery may be an option for people who are seriously affected by Alpha-1. In addition to medicines management ofPAlpha-1 include:

exercise and healthy lifestyle, including denial of smoking, P

Preventing infection

Oxygen therapy, breathing retraining

, P

pulmonary rehabilitation. and avoided. This is especially important to control the alpha-1. Smoking can speed up or accelerate the development of alpha-1-related emphysema and shorten the life. BACK.